Healthcare & Life Sciences
Gen1E
United States
aliveseries-a
series-a
Stage
1
Investors
About
Gen1E is a drug development company using an AI platform to identify treatments for rare inflammatory diseases including ARDS, ALS, and cystic fibrosis, and has completed Phase I trials for its lead ARDS compound.
Explore Gen1E's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.